MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jpm15080365

Медицинская библиотека · Journal of personalized medicine · 2025

EBV-Driven HLH and T Cell Lymphoma in a Child with X-Linked Agammaglobulinemia: A Genetically Confirmed Case Report and Literature Review.

Perez-Olais Jose Humberto, Mendoza-Coronel Elizabeth, Moreno-Ortega Jose Javier, Aguirre-Hernández Jesús, López-Herrera Gabriela, Yamazaki-Nakashimada Marco Antonio, Baeza-Capetillo Patricia, Godínez-Zamora Guadalupe Fernanda, Saucedo-Ramírez Omar Josue, Bonifaz Laura C, Fuentes-Pananá Ezequiel M

СтатьяПеревод в очереди

Аннотация

Introduction

X-linked agammaglobulinemia (XLA) is a prototypical inborn error of immunity (IEI) caused by mutations in the BTK gene, leading to a profound deficiency of mature B cells and severe pan-hypogammaglobulinemia. The Epstein-Barr virus (EBV), which primarily infects B lymphocytes, is believed to be unable to establish persistence in these patients due to the lack of its natural reservoir. Indeed, current evidence supports that EBV infection is typically refractory in individuals with XLA.

Methods

We describe the clinical and molecular characterization of a 10-year-old male patient with genetically confirmed XLA who developed EBV viremia, hemophagocytic lymphohistiocytosis (HLH), and EBV-positive cutaneous T cell lymphoma. Diagnosis was supported by flow cytometry, serology, quantitative PCR, EBER in situ hybridization, histopathology, and whole-exome sequencing.

Results

Despite the complete absence of peripheral B cells, EBV was detected in leukocytes and multiple tissues, indicating active infection. The patient developed HLH and a T cell lymphoma with EBER-positive infiltrates. Genetic analysis revealed a nonsense mutation in BTK (1558C>T, R520*), confirming XLA. The clinical course included multiple episodes of neutropenia, viral and bacterial infections, and severe systemic inflammation.

Conclusions

This is the first documented case of an XLA patient with confirmed BTK mutation presenting with clinical features more consistent with chronic active EBV infection. These findings challenge the prevailing paradigm that XLA confers protection against EBV-related diseases and further support the possibility of EBV noncanonical reservoirs leading to immune dysregulation. EBV should also be considered in the differential diagnosis of XLA patients presenting with systemic inflammation or lymphoproliferative disease.

Для цитирования: Perez-Olais Jose Humberto, Mendoza-Coronel Elizabeth, Moreno-Ortega Jose Javier, Aguirre-Hernández Jesús, López-Herrera Gabriela, Yamazaki-Nakashimada Marco Antonio, Baeza-Capetillo Patricia, Godínez-Zamora Guadalupe Fernanda, Saucedo-Ramírez Omar Josue, Bonifaz Laura C, Fuentes-Pananá Ezequiel M. EBV-Driven HLH and T Cell Lymphoma in a Child with X-Linked Agammaglobulinemia: A Genetically Confirmed Case Report and Literature Review.. Journal of personalized medicine. 2025. DOI: 10.3390/jpm15080365.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.